Curaleaf Laboratories and Vericura announce a new UK medical cannabis manufacturing and distribution agreement. Go to Source Author:
This autumn, a number of events across the UK and Europe will put conversations about women’s health centre stage. Go to Source Author:
State regulators are spending unnecessary time and money trying to police a private testing model that fails to protect consumers. From Maryland’s newly launched CSQ CLEAR audit pilot to New York’s shutdown of Lexachrom Analytical Laboratory, Michigan’s historic license revocations of Viridis Laboratories, and New Jersey [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.